Schedule 13G ownership disclosure

UNUM THERAPEUTICS INC

Security class unavailable · CUSIP: 903214104

Event date: 2020-08-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-096605
Form type
SC 13G/A
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Aug 19, 2020
Reporting period
Aug 13, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub